Ningxia Taiyixin was established in June 2010, is mainly dedicated to the R&D,production, sales of APIs, intermediates, and preparations. Construction started in September 2010.In October 2012, It was completed and started its trial production.

At present, the company has reached an annual output of 1,500 tons tylosin , 1,100 tons lincomycin, 700 tons avermectin, 1,000 tons Erythromycin thiocyanate, 450 tons ivermectin, and 1200tons Emamectin benzoate , 600tons tilmicosi , 400tons azithromycin, 200tons clarithromycin, 1550tons clindamycin hydrochloride and its derivatives.